1. |
孙艺红, 胡大一. 华法林仍然是人工心脏瓣膜置换术后长期抗凝的唯一选择. 中华心血管病杂志, 2013, 4(4): 266.
|
2. |
The Boston anticoagnintion trial for atrial fibrillation investigators. The effect of low—dose warfarin on the risk of stroke in patients with nonrheumaticatrial fibrilation. N Engl J Med, 1990, 323(22): 1505-1511.
|
3. |
David C, Richard W, Susan M, et a1. Stroke prevention in atrial fibrillation study: finalresults. Circulation, 1991, 84(2): 527-539.
|
4. |
Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA, 2001, 285(22): 2864-2870.
|
5. |
Yoon HW, Giraldo EA, Wijdicks EF. Valproic acid and warfarin: an underrecognized drug interaction. Neurocritical Care, 2011, 15(1): 182-185.
|
6. |
Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol, 2000, 22(3): 62-65.
|
7. |
Mannheimer B, Andersson ML, Jarnbert-Pettersson H, et al. The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population. Thrombosis and Haemostasis, 2016, 14(5): 765-771.
|
8. |
Clark NP, Hoang K, Delate T, et al. Warfarin interaction with hepatic cytochrome P-450 enzyme-inducing anticonvulsants. Clin Appl Thromb Hemost, 2018, 24(1): 172-178.
|
9. |
Krämer G, Tettenborn B, Klosterskov Jensen P, et al. Oxcarbazepine does not affect the anticoagulant activity of warfarin. Epilepsia, 1992, 33(6): 1145-1148.
|
10. |
Ahmed SN. Antiepileptic drugs and warfarin. Canadian Medical Association Journal, 2008, 178(1): 65, author reply 65.
|
11. |
Hassan Y, Awaisu A, Aziz NA, et al. The complexity of achieving anticoagulation control in the face of warfarin-phenytoin interaction: an asian case report. Pharm World Science, 2005, 27(1): 16-19.
|
12. |
Chtydodyomos P Panayiotopoulos. 吴立文 主审, 任连坤 主译. 癫痫发作和综合征的诊断与治疗. 中国协和医科大学出版社, 2008: 467.
|
13. |
Hamer HM. Seizures nd epilepsies after stroke. Nervenarzt, 2009, 80(4): 405-414.
|
14. |
Sayal KS, Duncan-McConnell DA, McConnell HW, et al. Psychotropic interaction with warfarin. Acta Psychiatr Scand, 2000, 102(4): 250-255.
|
15. |
Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clinical Pharmacokinet, 2004, 43(11): 707-724.
|